|
| |
Articles
1-142 out of 142 article(s)
| Title |
Author |
Type |
Date |
Words |
| RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer. |
|
|
May 16, 2013 |
630 |
| RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer. |
|
|
May 16, 2013 |
618 |
| Xencor Licenses Xtend(TM) Therapeutic Protein Half-life Extension Technology to CSL. |
|
|
Apr 16, 2013 |
643 |
| CytoDyn to Attend BIOCOM Global Life Sciences Partnering Conference. |
|
Conference news |
Feb 27, 2013 |
973 |
| United Kingdom : Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial. |
|
|
Jan 17, 2013 |
337 |
| arGEN-X Expands its Therapeutic Antibody Alliance With Shire. |
|
|
Jan 7, 2013 |
788 |
| arGEN-X Expands its Therapeutic Antibody Alliance With Shire. |
|
|
Jan 7, 2013 |
792 |
| OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1). |
|
|
Dec 21, 2012 |
881 |
| Synthetic Biologics and Intrexon Corporation Initiate Development of Monoclonal Antibodies for Whooping Cough (Pertussis). |
|
|
Dec 20, 2012 |
1851 |
| XBiotech Reports Positive Phase II Interim Analysis Results in Vascular Disease. |
|
Clinical report |
Nov 20, 2012 |
998 |
| CytoDyn Announces Phase IIB Clinical Trial Agreement with Dr. Jeffrey Jacobson, Drexel University College of Medicine. |
|
|
Nov 16, 2012 |
1275 |
| Research and Markets: Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area in the Pharmaceutical Industry. |
|
|
Oct 31, 2012 |
372 |
| Vaccine against deadly Ebola virus shows promise in monkeys. |
|
|
Oct 16, 2012 |
517 |
| Frost & Sullivan Predicts Growth for the Therapeutic Monoclonal Antibodies Market in Europe. |
|
|
Oct 10, 2012 |
956 |
| Frost & Sullivan Predicts Growth for the Therapeutic Monoclonal Antibodies Market in Europe. |
|
|
Oct 10, 2012 |
962 |
| United Kingdom : Frost & Sullivan Predicts Growth for the Therapeutic Monoclonal Antibodies Market in Europe. |
|
|
Oct 10, 2012 |
392 |
| CytoDyn Retains Gibraltar Associates for Corporate and Investor Communications. |
|
|
Oct 3, 2012 |
746 |
| Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections. |
|
|
Sep 18, 2012 |
1919 |
| United States : Theraclone Sciences Presents Phase 1 Results of TCN-032, its Therapeutic Antibody Directed at Influenza A, at ICAAC 2012. |
|
|
Sep 11, 2012 |
430 |
| New drug candidate gives 100pc protection against influenza. |
|
|
Sep 11, 2012 |
379 |
| Antibody prevents hepatitis c infection in chimpanzees. |
|
|
Sep 2, 2012 |
328 |
| Research and Markets: Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline. |
|
|
Jul 19, 2012 |
387 |
| Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline. |
|
|
Jul 17, 2012 |
4333 |
| Predictors of response to TNF inhibitors in rheumatoid arthritis: do we have new tools for personalized medicine? |
Simsek, Ismail |
|
Jul 1, 2012 |
2842 |
| Theraclone Sciences Announces Initiation of a Phase 1 Clinical Trial of TCN-202, an Antibody in Development for the Treatment of Human Cytomegalovirus Infection. |
|
Medical condition overview |
Jun 14, 2012 |
548 |
| Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of its Therapeutic Antibody Directed at Influenza A. |
|
|
May 15, 2012 |
584 |
| Emerging targeted therapies in cancer. |
Chirieac, Lucian R. |
|
May 1, 2012 |
907 |
| Antibody Drugs: Technologies and Global Markets. |
|
|
Mar 28, 2012 |
2999 |
| Antibody Drugs: Technologies and Global Markets. |
|
|
Mar 21, 2012 |
3582 |
| Access to antiretroviral treatment in South Africa, 2004-2011. |
Johnson, Leigh F. |
Report |
Mar 1, 2012 |
15233 |
| Roche's MagNA Pure LC 2.0 System for Monitoring DNA in Therapeutic Proteins and Monoclonal Antibody Drugs. |
|
|
Feb 29, 2012 |
573 |
| Roche's MagNA Pure LC 2.0 System for Monitoring DNA in Therapeutic Proteins and Monoclonal Antibody Drugs. |
|
|
Feb 29, 2012 |
567 |
| arGEN-X Enters Into a Therapeutic Antibody Alliance With Shire. |
|
|
Feb 29, 2012 |
925 |
| ARGEN-X ADVANCES A THIRD THERAPEUTIC ANTIBODY PROGRAM INTO PRECLINICAL DEVELOPMENT. |
|
|
Feb 8, 2012 |
796 |
| ARGEN-X ADVANCES A THIRD THERAPEUTIC ANTIBODY PROGRAM INTO PRECLINICAL DEVELOPMENT. |
|
|
Feb 8, 2012 |
800 |
| Immunoreactive evaluation of the extracellular epitope of prostate-specific membrane antigen: in Vitro diagnostic and therapeutic potential. |
Moffatt, Stanley S.; Ansie, Derrick E. |
|
Feb 1, 2012 |
5103 |
| Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret[R] against viruses causing respiratory infections. |
Glatthaar-Saalmuller, B.; Rauchhaus, U.; Rode, S.; Haunschild, J.; Saalmuller, A. |
Report |
Dec 15, 2011 |
5523 |
| Arsanis Receives Grant from the Austrian Research Promotion Agency for Pre-Clinical and Clinical Development of Monoclonal Antibodies Against Severe Nosocomial Infections. |
|
|
Oct 19, 2011 |
505 |
| ShangPharma Subsidiary and Jiangsu Hengrui Medicine Partner in Therapeutic Antibody Research and Development. |
|
|
Sep 15, 2011 |
1034 |
| Research and Markets: Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market. |
|
|
Sep 13, 2011 |
535 |
| Therapeutic Proteins Market Dominated by Roche, Amgen and Novo Nordisk: companiesandmarkets.com. |
|
|
Sep 6, 2011 |
446 |
| PX'Therapeutics Licenses RIBOVAX's SEBVI Technology for the Development and Manufacturing of Fully Human Monoclonal Antibodies. |
|
|
Jul 27, 2011 |
491 |
| ERG oncoprotein overexpression in prostate cancer multiplex IHC adds to diagnostic prowess and efficiency of laboratory. |
Cross, Mark |
|
Jul 1, 2011 |
1187 |
| New therapy that pushes colon cancer cells to death discovered. |
|
|
Jun 9, 2011 |
238 |
| Data on Neogenix Oncology's Phase I Study of Novel Therapeutic Antibody NPC-1C (Ensituximab) to be Presented at ASCO's 2011 Annual Meeting. |
|
|
Jun 3, 2011 |
660 |
| Aethlon Medical Introduces the Aethlon ADAPT(TM) System. |
|
|
May 19, 2011 |
1668 |
| Reportlinker Adds Pharmaceuticals Reports Bundle. |
|
|
May 16, 2011 |
2324 |
| Kyasanur forest disease virus alkhurma subtype in ticks, Najran Province, Saudi Arabia. |
Mahdi, Mustafa; Erickson, Bobbie Rae; Comer, J. Andy; Nichol, Stuart T.; Rollin, Pierre E.; AlMazroa |
Report |
May 1, 2011 |
1268 |
| OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP-18R5. |
|
|
Apr 28, 2011 |
717 |
| Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents. |
|
|
Apr 12, 2011 |
965 |
| Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis. |
Wu, Shang-Gin; Tsai, Tzu-Hsiu; Wu, Shang-Ju |
Letter to the editor |
Apr 1, 2011 |
1171 |
| Neogenix Oncology Novel Therapeutic Antibody, NEO-101 (Ensituximab) Data to Be Presented at AACR's 2011 Annual Symposium. |
|
|
Apr 1, 2011 |
710 |
| Rapid situation & response assessment of diarrhoea outbreak in a coastal district following tropical cyclone AILA in India. |
Panda, Samiran; Pati, Kamala Kanta; Bhattacharya, Mihir Kumar; Koley, Hemanta; Pahari, Sobha; Nair, |
Report |
Apr 1, 2011 |
3789 |
| Life work culminates in testing of cancer therapy in humans. |
|
|
Mar 24, 2011 |
418 |
| LILLY (ELI) & COMPANY - Necitumumab Trial DMC. |
|
|
Feb 3, 2011 |
2864 |
| Reportlinker Adds Biologic Therapeutic Drugs: Technologies and Global Markets. |
|
|
Jan 25, 2011 |
1572 |
| Data on Neogenix Oncology's Novel Therapeutic Antibody NPC-1C (Ensituximab) to be Presented at ASCO's 2011 Gastrointestinal Cancers Symposium. |
|
|
Jan 18, 2011 |
635 |
| OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5. |
|
|
Jan 10, 2011 |
747 |
| Alnylam Biotherapeutics Presents Data on New Applications of RNAi Technology for Biologics Manufacturing. |
|
|
Nov 18, 2010 |
1204 |
| Neogenix Oncology[R] Receives Two Grants Under The Qualifying Federal Therapeutic Discovery Project Program. |
|
|
Nov 9, 2010 |
516 |
| X-BODY BioSciences Awarded Grant for Therapeutic Discovery Project Targeting Metastatic Tumor Stem Cells. |
|
|
Nov 1, 2010 |
447 |
| Porcine xenotransplantation to primates. |
Min, T.S.; Han, H.J.; Park, S.H. |
Report |
Nov 1, 2010 |
6107 |
| Oligonol a low molecular weight polyphenol of lychee fruit extract inhibits proliferation of influenza virus by blocking reactive oxygen species-dependent ERK phosphorylation. |
Gangehei, Leila; Ali, Muzammil; Zhang, Wei; Chen, Zhenping; Wakame, Koji; Haidari, Mehran |
Report |
Nov 1, 2010 |
6263 |
| Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic. |
|
|
Oct 27, 2010 |
590 |
| Morphotek[R], Inc. Awarded $2.5 Million from U.S. Department of Defense to Continue Development of Therapeutic Antibodies Against Microbial Bioweapons. |
|
|
Oct 21, 2010 |
757 |
| FibroGen Initiates Phase 2 Clinical Study to Evaluate Efficacy of FG-3019, Human Monoclonal Antibody Against CTGF, in Reversing Liver Fibrosis. |
|
|
Oct 14, 2010 |
1316 |
| Progenics Awarded $4.1 Million NIH Grant to Advance Novel C. Difficile Antibody Therapy. |
|
|
Oct 6, 2010 |
1569 |
| Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer. |
|
|
Sep 29, 2010 |
592 |
| Morphotek[R], Inc. Announces Selection of a Therapeutic Monoclonal Antibody for Clinical Development under Terms of Collaboration with Human Genome Sciences. |
|
|
Sep 28, 2010 |
551 |
| Research and Markets: Cancer Targeted Therapies and Immunotherapies - Top Monoclonal Antibody Brands will Resist Competitive Pressures Through to 2019. |
|
|
Sep 10, 2010 |
467 |
| Monoclonal antibody improves survival in melanoma. |
McBride, Deborah |
Brief article |
Sep 1, 2010 |
202 |
| Gamma secretase and Notch as therapeutic targets in cancer. |
Filipovic, Aleksandra; Giamas, Georgios; Coombes, R. Charles; Stebbing, Justin |
|
Sep 1, 2010 |
3141 |
| Anti-interleukin-6 therapy in rheumatoid arthritis. |
Woodrick, Robert; Ruderman, Eric M. |
Report |
Jul 1, 2010 |
4134 |
| Aromatase inhibitors and bone health. |
Bundred, Nigel J. |
Clinical report |
Jul 1, 2010 |
4209 |
| Research and Markets: Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging Technologies and New Therapeutic Candidates. |
|
|
Jun 16, 2010 |
372 |
| Survival rate higher with melanoma Rx. |
Macneil, Jane Salodof |
|
Jun 15, 2010 |
386 |
| Emergent BioSolutions IND for Anthrax Monoclonal Antibody Therapeutic Clears FDA Review. |
|
|
May 17, 2010 |
569 |
| Caviar among the ruins. |
Gaby, Alan R. |
Editorial |
May 1, 2010 |
827 |
| High concentration of magnolol induces hepatotoxicity under serum-reduced conditions. |
Kao, Ying-Hsien; Jawan, Bruno; Sun, Cheuk-Kwan; Goto, Shigeru; Lin, Yu-Chun; Hung, Chun-Tzu; Pan, Me |
Report |
May 1, 2010 |
3853 |
| Acanthoic acid, a diterpene in Acanthopanax koreanum, protects acetaminophen-induced hepatic toxicity in mice. |
Wu, Yan-Ling; Jiang, Ying-Zi; Jin, Xue-Jun; Lian, Li-Hua; Piao, Juan-Yu; Wan, Ying; Jin, Hong-Ri; Le |
Report |
May 1, 2010 |
2833 |
| Hope for earlier diagnosis. |
|
Brief article |
Mar 15, 2010 |
175 |
| Human Genome Sciences and BioInvent Announce Collaboration to Co-Develop and Commercialize Therapeutic Antibodies. |
|
|
Mar 11, 2010 |
1082 |
| BioInvent and Human Genome Sciences Announce Collaboration to Co-develop and Commercialize Therapeutic Antibodies. |
|
|
Mar 11, 2010 |
1001 |
| Successful Development of Broad Spectrum Human Monoclonal Antibodies Against Major Influenza Viruses (H1N1 and H5N1). |
|
|
Mar 9, 2010 |
716 |
| arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development. |
|
|
Mar 1, 2010 |
967 |
| Kenta Biotech Announces Collaboration with Rentschler Biotechnologie for Antibody Development Against Hospital-Acquired Infections. |
|
|
Jan 14, 2010 |
575 |
| Affomix to Provide Antibodies for Kalgene Pharmaceutical's Therapeutic and Companion Diagnostics Program. |
|
|
Dec 29, 2009 |
580 |
| ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic TB-403 in Patients With Advanced Solid Tumours. |
|
|
Nov 16, 2009 |
1040 |
| FibroGen Announces New Research in Anti-CTGF and HIF-PHI Therapeutic Development Programs in Kidney Disease. |
|
Clinical report |
Nov 2, 2009 |
1551 |
| Effectiveness of rheolytic thrombectomy during percutaneous revascularization for ST-segment elevation myocardial infarction: a single center experience with the AngioJet catheter. |
Hulse, Ronald S., III; Stauffer, Marc R.; Jain, Abnash C.; Beto, Robert; Warden, Bradford; Gharib, W |
Report |
Nov 1, 2009 |
3140 |
| 15th Congress of the European Cancer Organization and the 34th European Society for Medical Oncology multidisciplinary congress: GI update. |
Brown, Vanessa |
Clinical report |
Oct 1, 2009 |
1840 |
| 4-Methoxycinnamaldehyde inhibited human respiratory syncytial virus in a human larynx carcinoma cell line. |
Wang, Kuo Chih; Chang, Jung San; Chiang, Lien Chai; Lin, Chun Ching |
Report |
Sep 1, 2009 |
2844 |
| Research and Markets: U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market From 2004 to 2014. |
|
|
Jun 4, 2009 |
158 |
| Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies. |
|
|
May 18, 2009 |
653 |
| Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection. |
|
|
Apr 21, 2009 |
1663 |
| Ustekinumab beats etanercept for psoriasis. |
Jancin, Bruce |
Brief article |
Apr 15, 2009 |
265 |
| ATCC Develops and Isolates Novel Avian Flu Monoclonal Antibodies. |
|
|
Mar 16, 2009 |
676 |
| The French Biopharmaceutical Group LFB Has Announced the First-in-Man Injections of Its First Two Therapeutic Monoclonal Antibodies and the Filing of BLAs for a New-Generation Immunoglobulin and a Fibrinogen. |
|
|
Feb 10, 2009 |
414 |
| FibroGen Announces New Research at Stanford University School of Medicine Indicates That Inhibiting CTGF Could Have Therapeutic Benefits in Treating Pancreatic Cancer. |
|
Clinical report |
Feb 3, 2009 |
1450 |
| Murine monoclonal anti-H as typing reagent. |
Iyer, Y.S.; Vasantha, K.; Pujari, V.; Jadhav, S.; Ghosh, K. |
Report |
Jan 1, 2009 |
1481 |
| Expression of class III [beta]-tubulin in colorectal carcinomas: an immunohistochemical study using TU-20 & TuJ-1 antibody. |
Jirasek, Tomas; Cipro, Simon; Musilova, A.; Kubecova, M.; Mandys, V. |
Report |
Jan 1, 2009 |
3323 |
| Morphotek[R], Inc. Announces Research Agreement with The University of Pennsylvania to Develop Oncology Therapeutic Antibody Candidates. |
|
|
Dec 22, 2008 |
632 |
| Acorda Therapeutics to Present an Overview of its Preclinical Pipeline at Windhover Therapeutic Area Partnerships Conference. |
|
Conference news |
Nov 3, 2008 |
468 |
| Mycobacterium haemophilum infection after alemtuzumab treatment. |
Kamboj, Mini; Louie, Eddie; Keihn, Timothy; Papanicolaou, Genovefa; Glickman, Michael; Sepkowitz, Ke |
|
Nov 1, 2008 |
1284 |
| The trials and errors in MS therapy. |
Kleinschnitz, Christoph; Meuth, Sven G.; Wiendl, Heinz |
Report |
Nov 1, 2008 |
8078 |
| Spotlight on anti-CD25: daclizumab in MS. |
Schippling, Sven; Martin, Roland |
|
Nov 1, 2008 |
3202 |
| Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy. |
|
|
Oct 3, 2008 |
751 |
| Morphotek(R), Inc. and Pivotal BioSciences Announce Agreement for the Development of Therapeutic Monoclonal Antibodies. |
|
|
Sep 25, 2008 |
558 |
| ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer. |
|
|
Sep 19, 2008 |
2056 |
| Use of Therapeutic Monoclonal Antibodies Increasing in Europe. |
|
|
Sep 15, 2008 |
539 |
| ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer. |
|
|
Jul 16, 2008 |
2133 |
| Novel agent promising for osteoarthritic knee pain. |
Jancin, Bruce |
|
Jul 15, 2008 |
595 |
| MHC Biologics Sets Sights on the Next Generation of Monoclonal Antibody Therapies. |
|
Company overview |
Jun 16, 2008 |
700 |
| KaloBios Initiates Phase 1/2 Trial of Humaneered(TM) Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Mechanically Ventilated Patients. |
|
|
May 19, 2008 |
443 |
| Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment. |
|
Report |
May 13, 2008 |
1018 |
| KaloBios Initiates Phase 1/2 Trial of Humaneered(TM) Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Cystic Fibrosis Patients. |
|
|
Mar 31, 2008 |
556 |
| Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis. |
Sarkissian, Gaiane; Fergelot, Patricia; Lamy, Pierre-Jean; Patard, Jean-Jacques; Culine, Stephane; J |
|
Mar 1, 2008 |
5208 |
| Psoriasis drug excels in phase III study. |
Finn, Robert |
Clinical report |
Feb 15, 2008 |
410 |
| Genitope Corporation Presents New Data On Its Therapeutic Monoclonal Antibodies To Potentially Treat B-Cell Malignancies. |
|
|
Dec 10, 2007 |
808 |
| Panacea announces selection of PAN-622 - a fully human sequence monoclonal antibody against HAAH - as its lead cancer therapeutic product. |
|
|
Nov 1, 2007 |
793 |
| Laureate Pharma to Produce Lpath's Breakthrough Therapeutic Antibody for Phase I Clinical Trials. |
|
|
Aug 22, 2006 |
820 |
| Progenics Pharmaceuticals Initiates Clinical Trial of Viral-Entry Inhibitor PRO 140 in HIV-Infected Patients; Monoclonal Antibody Designed to Block HIV Infection of Immune System Cells. |
|
|
Dec 1, 2005 |
1461 |
| Agensys and Merck Announce Agreement to Co-Develop and Commercialize a Novel Antibody for Cancer Therapy. |
|
|
Oct 17, 2005 |
975 |
| Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies. |
Moxness, Michael; Tatarewicz, Suzanna; Weeraratne, Dohan; Murakami, Nancy; Wullner, Danika; Mytych, |
|
Oct 1, 2005 |
1171 |
| Immunohistological analysis of normal and osteoarthritic human synovial tissue. |
Korkusuz, Petek; Dagdeviren, Attila; Eksioglu, Fatih; Ors, Ulken |
|
Jun 22, 2005 |
5095 |
| Cyclophosphamide, HuZAF effective for severe Crohn's. (Pilot Studies Reported). |
Jancin, Bruce |
|
Aug 15, 2002 |
405 |
| Ultrarapid, ultrasensitive one-step kinetic immunoassay for C-reactive Protein (CRP) in whole blood samples: measurement of the entire CRP concentration range with a single sample dilution. |
Tarkkinen, Piia; Palenius, Tom; Lovgren, Timo |
Report |
Feb 1, 2002 |
6072 |
| Omalizumab Cuts Inhaled Steroid Use in Allergic Asthma. |
BATES, BETSY |
|
Jul 15, 2001 |
426 |
| Arthritis drug succeeds vs. psoriasis. |
N.S. |
Brief Article |
Jul 14, 2001 |
336 |
| Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus. |
Rickert, Mathias; Seissler, Jochen; Dangel, Werner; Lorenz, Helga; Richter, Wiltrud |
|
May 1, 2001 |
4831 |
| An IgM [lambda] antibody to Escherichia coli produces false-positive results in multiple immunometric assays. |
Covinsky, Michael; Laterza, Omar; Pfeifer, John D.; Farkas-Szallasi, Tunde; Scott, Mttchell G. |
|
Aug 1, 2000 |
3391 |
| Rapid diagnosis of herpes simplex encephalitis using microchip electrophoresis of PCR products. |
Hofgartner, Wolfgang T.; Huhmer, Andreas F.R.; Landers, James P.; Kant, Jeffrey A. |
|
Dec 1, 1999 |
5962 |
| Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. |
Bieche, Ivan; Onody, Peter; Laurendeau, Ingrid; Olivi, Martine; Vidaud, Dominique; Lidereau, Rosette |
|
Aug 1, 1999 |
5839 |
| Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases. |
Whaley, Kevin J. |
Statistical Data Included |
Jan 1, 1999 |
7646 |
| New MAB trials need participants. |
|
|
Sep 22, 1998 |
190 |
| Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. |
Cogill, Jan L.; Taylor, Paul J.; Westley, Ian S.; Morris, Raymond G.; Lynch, Stephen V.; Johnson, An |
Clinical report |
Sep 1, 1998 |
3050 |
| Antibody combo nixes graft rejection. |
Ezzell, Carol |
|
Feb 29, 1992 |
693 |
| A medical "smart-bomb" to save septicemia victims. |
|
|
Mar 1, 1991 |
426 |
| Novel antibodies beat bacterial toxins. |
Weiss, Rick |
|
Feb 16, 1991 |
518 |
| Melanoma shrinks from human monoclonals. |
Weiss, Rick |
|
May 26, 1990 |
599 |
| Compelling cancer cells to self-destruct. |
Hart, S. |
|
Jul 29, 1989 |
536 |
| Therapeutic monoclonal antibody okayed. |
Silberner, Joanane |
|
Jun 28, 1986 |
468 |
|
